Nicholas A. Peppas, Sc.D.
Peppas has had numerous recognitions by academies, universities, companies and organizations in the USA, Canada, Mexico, France, Italy, Spain, Portugal, Belgium, UK, Germany, Denmark, Switzerland, Italy, Slovenia, Serbia, Greece, Turkey, Saudi Arabia, Israel, Czechia, India, China, Korea, Japan and Singapore.
His work on biomaterials, drug delivery, bionanotechnology and nanomaterials follows a multidisciplinary approach by blending modern molecular and cellular biology with engineering principles to design the next generation of therapeutic agent release systems for treatment of diabetes, autoimmune and cardiovascular diseases, medical systems, and devices for patient treatment. His contributions have been translated into more than twenty medical products with multibillion dollar markets. It is estimated that 800 million patients have benefited from the products that have come out of the fundamental principles, translational research, development and commercialization efforts of Professor Peppas via new companies, devices, and drug delivery systems. Over the past four decades, he has set the fundamentals and rational design of biomedical systems and developed models of drug and protein diffusion in controlled release devices and biological tissues.